原发性子宫内膜肝样腺癌18F-FDG PET/CT罕见病例
本文报道一例64岁女性阴道出血2个月、血清甲胎蛋白显著升高至3931 ng/mL的病例。宫腔镜分段诊刮提示子宫内膜腺癌,腹部增强CT未见肝脏病变排除原发性肝癌,分期18F-FDG PET/CT显示子宫内膜高代谢肿块,术后病理诊断为原发性子宫内膜肝样腺癌。
要点
- 原发性子宫内膜肝样腺癌是罕见肿瘤,可表现为阴道出血伴血清甲胎蛋白显著升高。
- 18F-FDG PET/CT可用于显示子宫内膜高代谢肿块并协助分期。
- 腹部增强CT未见肝脏病变有助于排除原发性肝癌。
核心结论
- 原发性子宫内膜肝样腺癌为罕见肿瘤,本例经术后病理确诊。
研究设计与样本
- 单例病例报道:64岁女性,阴道出血2个月,血清甲胎蛋白3931 ng/mL。
主要发现
- 宫腔镜分段诊刮提示子宫内膜腺癌。
- 盆腔MRI显示仅子宫内膜肿块。
- 腹部增强CT未见肝脏病变,排除原发性肝癌。
- 分期18F-FDG PET/CT显示子宫内膜高代谢肿块。
- 行全子宫切除加双侧附件切除及区域淋巴结清扫,术后病理诊断为原发性子宫内膜肝样腺癌。
临床怎么用
- 对阴道出血伴甲胎蛋白显著升高的患者,应将子宫内膜肝样腺癌纳入鉴别诊断。
- 18F-FDG PET/CT可用于显示子宫内膜高代谢肿块并协助分期。
- 腹部增强CT未见肝脏病变有助于排除原发性肝癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary endometrial hepatoid adenocarcinoma is a rare tumor. We present a case of a 64-year-old woman with vaginal bleeding for 2 months and a markedly elevated serum α-fetoprotein of 3931 ng/mL. Hysteroscopic segmental curettage revealed endometrial adenocarcinoma. A pelvic MRI was performed for local tumor invasion, which showed only endometrial mass. An abdominal enhanced CT showed no liver lesion, which excluded primary hepatic carcinoma. Staging F-FDG PET/CT demonstrated a hypermetabolic mass in the endometrium. A total hysterectomy with bilateral salpingo-oophorectomy and regional lymphadenectomy were performed. Postoperatively, the mass was diagnosed as primary endometrial hepatoid adenocarcinoma.
引用
- Yin H, Hu Y, Xiu Y, et al. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT. Clin Nucl Med. 2019. PMID: 30985410. doi:10.1097/RLU.0000000000002538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。